MedPath

An Evaluation of the Effectiveness of Ibuprofen and Morphine for Acute Pain in Sickle Cell Disease - Ibuprofen and Morphine for Acute Sickle Cell Pai

Phase 1
Conditions
Sickle Cell Disease
Registration Number
EUCTR2008-006846-24-GB
Lead Sponsor
orth West London Hospitals NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
320
Inclusion Criteria

Adult patients with SCD of any phenotype and gender aged 16 years and over
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Patient has a history of allergic reaction to either morphine or ibuprofen
2. Patient has contraindications to morphine or ibuprofen, e.g. peptic ulcer disease, NSAID-induced asthma
3. Patient in a drug dependency programme
4. Patient is on renal dialysis
5. Stroke within the last 6 weeks
6. Platelet count < 50 X 10E9/l
7. Patient is pregnant or breastfeeding
8. Doctor unwilling to randomise the patient for other reasons
9. Previous participation in the trial

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath